One study explored the potential risk of sarcopenia among carriers of PNPLA3 variants; DEXA-derived ASM independently decreased in NAFLD patients carrying the wild type gene, but no association was found among PNPLA3 subjects who carried the risk allele (77). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.